Henrik Dahllöf

Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i> -[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile

Stefan Werner, Stefanie Mesch, R.C. Hillig et al. · Journal of Medicinal Chemistry · 2019 · 55 citations · Full text

Discovery and characterization of AZD9272 and AZD6538—Two novel mGluR5 negative allosteric modulators selected for clinical development

Patrick Raboisson, Anna Breitholtz‐Emanuelsson, Henrik Dahllöf et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 38 citations · Full text

Negative Allosteric Modulators, Molecular Pharmacology, G Protein-coupled Receptor +6

Dynamic weight bearing as a non‐reflexive method for the measurement of abdominal pain in mice

Alexis Laux‐Biehlmann, Janina Boyken, Henrik Dahllöf et al. · European Journal of Pain · 2015 · 27 citations

Roles of TRPA1 in Pain Pathophysiology and Implications for the Development of a New Class of Analgesic Drugs

Olivier Radresa, Henrik Dahllöf, Eva Nyman et al. · The Open Pain Journal · 2013 · 19 citations · Full text

Pain Therapy, Pain Medicine, Neuropathic Pain +24